89 related articles for article (PubMed ID: 3228752)
1. [The inducing effect of retinoic acid and harringtonine on differentiation of human leukemic cells in primary culture].
Ji H
Zhonghua Yi Xue Za Zhi; 1988 Sep; 68(9):509-12, 36. PubMed ID: 3228752
[No Abstract] [Full Text] [Related]
2. [Ultrastructural studies on differentiation of human leukemic cell induced by retinoic acid and harringtonine].
Si JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):376-8. PubMed ID: 2978260
[No Abstract] [Full Text] [Related]
3. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
Chen ZX; Wang W; Wu WL
Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
[TBL] [Abstract][Full Text] [Related]
4. [Retinoic acid effect on the differentiation of blast cells in suspension].
Burgaleta C; Moreno T; Sánchez Godoy P
Sangre (Barc); 1989 Jun; 34(3):186-90. PubMed ID: 2762980
[TBL] [Abstract][Full Text] [Related]
5. [Electron microscopic observation of differentiation of leukemic cell clone after CFU-Mix culture].
Chen Y
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):268-70. PubMed ID: 2272260
[TBL] [Abstract][Full Text] [Related]
6. Antileukemic effect of low-dose harringtonine.
Chen SS; Wang P; Fu JY; Chen LL; Zhao FS; Shan FX
Chin Med J (Engl); 1989 Jun; 102(6):416-9. PubMed ID: 2512060
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the sensitivity of retinoic acid sensitive and resistant HL-60 cell lines to several anti-leukemia drugs].
Li L; Xia L; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Dec; 16(6):469-72. PubMed ID: 7720148
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid might also induce apoptosis in freshly isolated chronic myeloid leukemia cells.
Stagno F; Consoli U; Cacciola E
Haematologica; 1997; 82(1):125. PubMed ID: 9107100
[No Abstract] [Full Text] [Related]
9. [Retinoic acid intensifies the suppression of the proliferation of K562 cells by phorbol ester].
Chistokhina AV; Medvedev AV
Tsitologiia; 1993; 35(8):52-8. PubMed ID: 8266575
[TBL] [Abstract][Full Text] [Related]
10. [Blast differentiation in a patient with chronic myeloid leukemia in blast crisis using retinoic acid].
Burgaleta C; Villalba S; Ferro MT
Sangre (Barc); 1995 Dec; 40(6):509-12. PubMed ID: 8850236
[TBL] [Abstract][Full Text] [Related]
11. [Growth inhibition of human myeloid leukemia cells in vitro by harringtonine].
Piao YF; Okabe T; Zhang LJ
Gan To Kagaku Ryoho; 1990 Feb; 17(2):281-5. PubMed ID: 2301953
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow fibroblasts-conditioned medium regulates the proliferation of leukemic cells.
Kubota T; Nagao T; Arimori S
Tokai J Exp Clin Med; 1988 Feb; 13(1):45-51. PubMed ID: 3232161
[TBL] [Abstract][Full Text] [Related]
13. Leukemic colony formation from patients with acute leukemia: evidence of the identity in karyotype of the colonies from patients with cytogenetic abnormalities.
Ishibashi T
Fukushima J Med Sci; 1987 Dec; 33(2):71-83. PubMed ID: 3509037
[No Abstract] [Full Text] [Related]
14. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
[TBL] [Abstract][Full Text] [Related]
15. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
17. Small-dose Harringtonine induces complete remission in patients with acute promyelocytic leukemia.
Ye JS; Wang XH; Feng GH; Liang GR; Liu ZP
Leukemia; 1988 Jul; 2(7):427-9. PubMed ID: 3164799
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia as a model of cancer development.
Butturini A; Gale RP
Semin Oncol; 1995 Aug; 22(4):374-9. PubMed ID: 7638634
[No Abstract] [Full Text] [Related]
19. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
Fei J; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
[TBL] [Abstract][Full Text] [Related]
20. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
